334 related articles for article (PubMed ID: 25341038)
1. JNK-NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress.
Kostecka A; Sznarkowska A; Meller K; Acedo P; Shi Y; Mohammad Sakil HA; Kawiak A; Lion M; Królicka A; Wilhelm M; Inga A; Zawacka-Pankau J
Cell Death Dis; 2014 Oct; 5(10):e1484. PubMed ID: 25341038
[TBL] [Abstract][Full Text] [Related]
2. TAp73-mediated the activation of c-Jun N-terminal kinase enhances cellular chemosensitivity to cisplatin in ovarian cancer cells.
Zhang P; Liu SS; Ngan HY
PLoS One; 2012; 7(8):e42985. PubMed ID: 22900074
[TBL] [Abstract][Full Text] [Related]
3. The p73 tumor suppressor is targeted by Pirh2 RING finger E3 ubiquitin ligase for the proteasome-dependent degradation.
Jung YS; Qian Y; Chen X
J Biol Chem; 2011 Oct; 286(41):35388-35395. PubMed ID: 21852228
[TBL] [Abstract][Full Text] [Related]
4. Ligation of CD47 induces G1 arrest in EBV-transformed B cells through ROS generation, p38 MAPK/JNK activation, and Tap73 upregulation.
Park GB; Bang SR; Lee HK; Kim D; Kim S; Kim JK; Kim YS; Hur DY
J Immunother; 2014; 37(6):309-20. PubMed ID: 24911792
[TBL] [Abstract][Full Text] [Related]
5. Chaetocin-induced ROS-mediated apoptosis involves ATM-YAP1 axis and JNK-dependent inhibition of glucose metabolism.
Dixit D; Ghildiyal R; Anto NP; Sen E
Cell Death Dis; 2014 May; 5(5):e1212. PubMed ID: 24810048
[TBL] [Abstract][Full Text] [Related]
6. A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73.
Asher G; Tsvetkov P; Kahana C; Shaul Y
Genes Dev; 2005 Feb; 19(3):316-21. PubMed ID: 15687255
[TBL] [Abstract][Full Text] [Related]
7. TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity.
Chen D; Ming L; Zou F; Peng Y; Van Houten B; Yu J; Zhang L
Oncotarget; 2014 Sep; 5(18):8107-22. PubMed ID: 25237903
[TBL] [Abstract][Full Text] [Related]
8. Activation of Akt and JNK/Nrf2/NQO1 pathway contributes to the protective effect of coptisine against AAPH-induced oxidative stress.
Hu YR; Ma H; Zou ZY; He K; Xiao YB; Wang Y; Feng M; Ye XL; Li XG
Biomed Pharmacother; 2017 Jan; 85():313-322. PubMed ID: 27903425
[TBL] [Abstract][Full Text] [Related]
9. PLK2 phosphorylates and inhibits enriched TAp73 in human osteosarcoma cells.
Hu ZB; Liao XH; Xu ZY; Yang X; Dong C; Jin AM; Lu H
Cancer Med; 2016 Jan; 5(1):74-87. PubMed ID: 26625870
[TBL] [Abstract][Full Text] [Related]
10. CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer.
Lu H; Yan C; Quan XX; Yang X; Zhang J; Bian Y; Chen Z; Van Waes C
Neoplasia; 2014 Oct; 16(10):789-800. PubMed ID: 25379016
[TBL] [Abstract][Full Text] [Related]
11. NRH:quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20s proteasomal degradation leading to stabilization and activation of p53.
Gong X; Kole L; Iskander K; Jaiswal AK
Cancer Res; 2007 Jun; 67(11):5380-8. PubMed ID: 17545619
[TBL] [Abstract][Full Text] [Related]
12. Runt-related transcription factor 2 attenuates the transcriptional activity as well as DNA damage-mediated induction of pro-apoptotic TAp73 to regulate chemosensitivity.
Ozaki T; Sugimoto H; Nakamura M; Hiraoka K; Yoda H; Sang M; Fujiwara K; Nagase H
FEBS J; 2015 Jan; 282(1):114-28. PubMed ID: 25331851
[TBL] [Abstract][Full Text] [Related]
13. Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition.
Zhou X; Hao Q; Zhang Q; Liao JM; Ke JW; Liao P; Cao B; Lu H
Cell Death Differ; 2015 May; 22(5):755-66. PubMed ID: 25301064
[TBL] [Abstract][Full Text] [Related]
14. Melphalan-induced apoptosis of EBV-transformed B cells through upregulation of TAp73 and XAF1 and nuclear import of XPA.
Park GB; Kim YS; Kim D; Kim S; Lee HK; Cho DH; Lee WJ; Hur DY
J Immunol; 2013 Dec; 191(12):6281-91. PubMed ID: 24249729
[TBL] [Abstract][Full Text] [Related]
15. TAp73 and ΔNp73 have opposing roles in 5-aza-2'-deoxycytidine-induced apoptosis in breast cancer cells.
Lai J; Yang F; Zhang W; Wang Y; Xu J; Song W; Huang G; Gu J; Guan X
Mol Cells; 2014 Aug; 37(8):605-12. PubMed ID: 25134538
[TBL] [Abstract][Full Text] [Related]
16. p53 inactivation upregulates p73 expression through E2F-1 mediated transcription.
Tophkhane C; Yang SH; Jiang Y; Ma Z; Subramaniam D; Anant S; Yogosawa S; Sakai T; Liu WG; Edgerton S; Thor A; Yang X
PLoS One; 2012; 7(8):e43564. PubMed ID: 22952705
[TBL] [Abstract][Full Text] [Related]
17. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
[TBL] [Abstract][Full Text] [Related]
18. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
Asher G; Lotem J; Sachs L; Kahana C; Shaul Y
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13125-30. PubMed ID: 12232053
[TBL] [Abstract][Full Text] [Related]
19. TAp73 opposes tumor angiogenesis by promoting hypoxia-inducible factor 1α degradation.
Amelio I; Inoue S; Markert EK; Levine AJ; Knight RA; Mak TW; Melino G
Proc Natl Acad Sci U S A; 2015 Jan; 112(1):226-31. PubMed ID: 25535359
[TBL] [Abstract][Full Text] [Related]
20. Regulation of p73-mediated apoptosis by c-Jun N-terminal kinase.
Jones EV; Dickman MJ; Whitmarsh AJ
Biochem J; 2007 Aug; 405(3):617-23. PubMed ID: 17521288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
